SCHEMBL27775433

SCHEMBL27775433

[CH2]Cc1ccnc(-c2cccc(O)c2)n1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 8/20 0.52
PIK3CD O00329 8/20 0.52
HSD17B2 P37059 7/20 0.49
HSD17B1 P14061 6/20 0.49
CYP19A1 P11511 2/20 0.48
CYP3A4 P08684 4/20 0.40
CYP2C9 P11712 3/20 0.40
SREBF2 Q12772 1/20 0.40
RIPK1 Q13546 1/20 0.39
CYP17A1 P05093 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
ESR1 P03372 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2B6 P20813 1/20 0.39
CYP2C19 P33261 1/20 0.39
ESR2 Q92731 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28853231 0.80 MAPT (0.42) CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL25719743 0.76 HSD17B2 (0.53) PIK3CAPIK3CDHSD17B2HSD17B1CYP19A1
SCHEMBL27612438 0.76 PIK3CA (0.58) PIK3CAPIK3CDHSD17B2HSD17B1CYP19A1
SCHEMBL27625438 0.75 HSD17B1 (0.68) PIK3CAPIK3CDHSD17B2HSD17B1CYP19A1
SCHEMBL27034875 0.72 HSD17B1 (0.63) PIK3CAPIK3CDHSD17B2HSD17B1CYP19A1
SCHEMBL23868941 0.71 HSD17B1 (0.74) HSD17B2HSD17B1CYP19A1CYP3A4CYP2C9
SCHEMBL25458520 0.71 CYP1A2 (0.46) PIK3CAPIK3CDHSD17B2HSD17B1CYP19A1
SCHEMBL9801818 0.70 PIK3CA (0.46) PIK3CAPIK3CDHSD17B2HSD17B1CYP19A1
SCHEMBL5172881 0.69 PIK3CA (1.00) PIK3CAPIK3CD
SCHEMBL23630338 0.68 HSD17B1 (0.62) PIK3CAPIK3CDHSD17B2HSD17B1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101679432-A Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors SIGNAL PHARM LLC 2010-03-24 CN disclosed